UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial

Breast cancer research and treatment, 2020-05, Vol.181 (1), p.61-68

2020

Volltextzugriff (PDF)

A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance

NPJ precision oncology, 2024-03, Vol.8 (1), p.78-78, Article 78

2024

Volltextzugriff (PDF)

Notes for developing a molecular test for the full characterization of circulating tumor cells

Chinese journal of cancer research, 2015-10, Vol.27 (5), p.471-478

2015

Volltextzugriff (PDF)

Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial

The oncologist (Dayton, Ohio), 2021-09, Vol.26 (9), p.740-750

2021

Volltextzugriff (PDF)

Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer

Journal of thoracic disease, 2017-10, Vol.9 (Suppl 13), p.S1346-S1358

2017

Volltextzugriff (PDF)

Single tube liquid biopsy for advanced non‐small cell lung cancer

International journal of cancer, 2019-06, Vol.144 (12), p.3127-3137

2019

Volltextzugriff (PDF)

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer

Oncotarget, 2020-11, Vol.11 (45), p.4115-4122

2020

Volltextzugriff (PDF)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

Translational lung cancer research, 2021-01, Vol.10 (1), p.80-92

2021

Volltextzugriff (PDF)

Prognostic and predictive role of CTCs and AR-V7+ CTCs expression in metastatic catrate resistant prostate cancer (mCRPC): A feasibility study

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.367-367

2018

Volltextzugriff (PDF)

Monitoring and characterization of Circulating Tumor Cells (CTCs) in a patient with EML4-ALK positive Non Small Cell Lung Cancer (NSCLC)

Clinical lung cancer, 2016-09, Vol.17 (5), p.e173-e177

2016

Volltextzugriff (PDF)

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared

Journal of thoracic disease, 2017-10, Vol.9 (Suppl 13), p.S1391-S1396

2017

Volltextzugriff (PDF)

Association between insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) and prognosis in patients with metastatic breast cancer (MBC)

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1086-1086

2017

Volltextzugriff (PDF)

Abstract 379: Circulating tumor cells (CTCs) in clinically localized prostate cancer (PCa): searching a prognostic tool

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.379-379

2015

Volltextzugriff (PDF)

Abstract 387: Non small cell lung cancer and circulating tumor cell: A different expression of EpCam and cytokeratins

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.387-387

2015

Volltextzugriff (PDF)

Prognostic role of circulating tumor cells-CTCs in metastatic renal cell carcinoma

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.4568-4568

2017

Volltextzugriff (PDF)

Are circulating tumor cells (CTCs) a feasible tool for predicting disease recurrence and survival in nonmetastatic (M0) colorectal cancer (CRC)?

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.650-650

2015

Volltextzugriff (PDF)

Functional avidity-driven activation-induced cell death shapes CTL immunodominance

The Journal of immunology (1950), 2014-11, Vol.193 (9), p.4704-4711

2014

Volltextzugriff (PDF)

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients

Oncoscience, 2014, Vol.1 (1), p.49-56

2014

Volltextzugriff (PDF)

Potential applications of circulating melanoma cells (CMCs) expressing γ-H2AX

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e22036-e22036

2013

Volltextzugriff (PDF)

A Large Number of T Lymphocytes Recognize Moloney-Murine Leukemia Virus-Induced Antigens, but a Few Mediate Long-Lasting Tumor Immunosurveillance

The Journal of immunology (1950), 2005-05, Vol.174 (9), p.5398-5406

2005

Volltextzugriff (PDF)

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor

Frontiers in pediatrics, 2021, Vol.9, p.652583-652583

2021

Volltextzugriff (PDF)

Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice

The Journal of immunology (1950), 1991-10, Vol.147 (7), p.2284-2289

1991

Volltextzugriff (PDF)

Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials

Internal and emergency medicine, 2024, Vol.19 (1), p.71-79

2024

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Aktive Filter

KollektionIngenta

ThemaEngineering

ThemaObstetrics & Gynecology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(27)

Publikationsform

Sprache

Englisch
(30)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial

A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance

Notes for developing a molecular test for the full characterization of circulating tumor cells

Prognostic Role of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma: A Large, Multicenter, Prospective Trial

Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer

Evaluation of Circulating Endothelial Cells (CECs) As Marker of Endothelial Damage in Allo-Transplanted Patients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS): The Cecinvod Study

Single tube liquid biopsy for advanced non‐small cell lung cancer

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients

Prognostic and predictive role of CTCs and AR-V7+ CTCs expression in metastatic catrate resistant prostate cancer (mCRPC): A feasibility study

Monitoring and characterization of Circulating Tumor Cells (CTCs) in a patient with EML4-ALK positive Non Small Cell Lung Cancer (NSCLC)

Liquid biopsy for monitoring anaplastic lymphoma kinase inhibitors in non-small cell lung cancer: two cases compared

Association between insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) and prognosis in patients with metastatic breast cancer (MBC)

Evaluation of Circulating Endothelial Cells as Direct Marker of Endothelial Damage in Allo-Transplant Recipients at High Risk of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome

Abstract 379: Circulating tumor cells (CTCs) in clinically localized prostate cancer (PCa): searching a prognostic tool

Abstract 387: Non small cell lung cancer and circulating tumor cell: A different expression of EpCam and cytokeratins

Prognostic role of circulating tumor cells-CTCs in metastatic renal cell carcinoma

Are circulating tumor cells (CTCs) a feasible tool for predicting disease recurrence and survival in nonmetastatic (M0) colorectal cancer (CRC)?

Functional avidity-driven activation-induced cell death shapes CTL immunodominance

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients

Potential applications of circulating melanoma cells (CMCs) expressing γ-H2AX

A Large Number of T Lymphocytes Recognize Moloney-Murine Leukemia Virus-Induced Antigens, but a Few Mediate Long-Lasting Tumor Immunosurveillance

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor

Moloney murine leukemia virus tolerance in anti-CD4 monoclonal antibody-treated adult mice

Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials

Aktive Filter

Suchergebnisse filtern